We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.05B
AUM Growth
+$688M
(+11%)
Cap. Flow
+$306M
Cap. Flow
% of AUM
4.35%
Top 10 Holdings %
Top 10 Hldgs %
15.99%
Holding
1,149
New
136
Increased
453
Reduced
359
Closed
174
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$40.4M |
| 2 |
Amazon
AMZN
|
+$35M |
| 3 |
TJX Companies
TJX
|
+$34.6M |
| 4 |
Phillips 66
PSX
|
+$33.1M |
| 5 |
Mastercard
MA
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$31.7M |
| 2 |
Cigna
CI
|
+$27.3M |
| 3 |
Meta Platforms (Facebook)
META
|
+$21.6M |
| 4 |
JPMorgan Chase
JPM
|
+$21M |
| 5 |
Marvell Technology
MRVL
|
+$20.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.29% |
| 2 | Financials | 17.18% |
| 3 | Consumer Discretionary | 12.24% |
| 4 | Industrials | 11.66% |
| 5 | Healthcare | 10.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BNCL
751
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $571K | 0.01% |
33,778
+5,118
| +18% | +$87.5K |
|
|
AGTC
752
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $565K | 0.01% |
77,359
+7,500
| +11% | +$32.8K |
|
753
DHI Group
DHX
$166M
| $564K | 0.01% |
268,677
+208,333
| +345% | +$439K |
|
|
TNAV
754
DELISTED
Telenav Inc.
TNAV
| $564K | 0.01% |
111,711
+17,199
| +18% | +$94.4K |
|
|
ISEE
755
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $563K | 0.01% |
238,747
+11,621
| +5% | +$29K |
|
756
Cavco Industries
CVCO
$4.39B
| $562K | 0.01% |
2,220
-350
| -14% | -$81K |
|
|
EMCI
757
DELISTED
EMC INS Group Inc
EMCI
| $562K | 0.01% |
22,731
+4,100
| +22% | +$108K |
|
|
HABT
758
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $549K | 0.01% |
34,392
+14,100
| +69% | +$202K |
|
759
Northeast Bank
NBN
$1.11B
| $544K | 0.01% |
25,080
+80
| +0.3% | +$1.75K |
|
760
Universal Insurance Holdings
UVE
$1.16B
| $540K | 0.01% |
11,120
+630
| +6% | +$27.1K |
|
761
Qualys
QLYS
$4.84B
| $536K | 0.01% |
6,020
-480
| -7% | -$43.2K |
|
762
CenterPoint Energy
CNP
$29.1B
| $533K | 0.01% |
19,277
-7,660
| -28% | -$215K |
|
|
MOFG
763
DELISTED
MidWestOne Financial Group
MOFG
| $531K | 0.01% |
+15,930
| New | +$534K |
|
|
CCXI
764
DELISTED
ChemoCentryx, Inc.
CCXI
| $530K | 0.01% |
41,908
-1,800
| -4% | -$21.7K |
|
765
Idacorp
IDA
$8.23B
| $526K | 0.01% |
5,300
-90
| -2% | -$8.67K |
|
|
BFYT
766
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $524K | 0.01% |
8,500
| – | – |
|
|
CDTX
767
DELISTED
Cidara Therapeutics
CDTX
| $523K | 0.01% |
5,939
+1,705
| +40% | +$150K |
|
768
Vaalco Energy
EGY
$594M
| $523K | 0.01% |
191,719
+94,350
| +97% | +$248K |
|
769
Veeco
VECO
$3.15B
| $522K | 0.01% |
50,906
-35,600
| -41% | -$445K |
|
770
AngioDynamics
ANGO
$562M
| $519K | 0.01% |
23,864
-191,214
| -89% | -$4.25M |
|
|
GTY
771
Getty Realty Corp
GTY
$2.1B
| $518K | 0.01% |
18,124
+5,200
| +40% | +$149K |
|
772
Syndax Pharmaceuticals
SNDX
$1.84B
| $516K | 0.01% |
63,915
+23,100
| +57% | +$165K |
|
|
LTS
773
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $516K | 0.01% |
191,095
+110,385
| +137% | +$356K |
|
|
CXP
774
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $515K | 0.01% |
21,792
-800
| -4% | -$18.6K |
|
|
PSB
775
DELISTED
PS Business Parks, Inc.
PSB
| $513K | 0.01% |
4,040
+2,210
| +121% | +$285K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2018 Portfolio in Review
As of Q3 2018, Jacobs Levy Equity Management held 1,149 positions worth $7.05B, up 11% from $6.36B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $306M of net new capital in Q3 2018, opening 136 new positions and adding to 453 existing holdings. Its largest new stake was TJX Companies: 673,440 shares worth $37.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Eli Lilly, an estimated $31.7M trimmed.
- Jacobs Levy Equity Management's largest Q3 2018 buy was TJX Companies: 673,440 shares worth $37.7M.
- Jacobs Levy Equity Management added most to Alphabet (Google) Class C in Q3 2018, an estimated $40.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2018 reduction was Eli Lilly, cutting an estimated $31.7M.
- Jacobs Levy Equity Management fully exited Dun & Bradstreet in Q3 2018, selling an estimated $17.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $7.05B portfolio in Q3 2018.
- Jacobs Levy Equity Management opened 136 new positions and closed 174 in Q3 2018.
- Jacobs Levy Equity Management's portfolio value rose 11% quarter-over-quarter to $7.05B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2018, filed 14 Nov 2018.